Reports

To assist health care providers, policy makers, and consumers in making well-informed decisions about the prescribing and use of blood glucose test strips, our completed research and resulting recommendations will be available in a series of Optimal Therapy Reports that provide:

• evidence-based clinical statements and cost-effectiveness statements
• a clear picture of current practice in Canada regarding the use of blood glucose test strips
• an analysis of the quantity of blood glucose test strips prescribed, including market share and cost information
• an outline of gaps between current prescribing and use.

Currently available:

• Summary Reports:

  Executive Summary (9 pages. re: clinical reports)

  Project in Brief (one page, re: clinical reports)

• Final reports:

  Gap Analysis and Key Messages for the Prescribing and Use of Blood Glucose Test Strips for the Self-Monitoring of Blood Glucose. Optimal Therapy Report - COMPUS 2009; 3(7)

  Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose Test Strips. Optimal Therapy Report – COMPUS 2009, 3(6)

  Current Practice Analysis of Health Care Providers and Patients on Self-Monitoring of Blood Glucose. Optimal Therapy Report - COMPUS 2009; 3(5)

  Current Utilization of Blood Glucose Test Strips in Canada. Optimal Therapy Report – COMPUS 2009; 3(4)

  Cost Effectiveness of Blood Glucose Test Strips in the Management of Adult Patients with Diabetes Mellitus. Optimal Therapy Report – COMPUS 2009; 3(3)

  Systematic Review of Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus. Optimal Therapy Report – COMPUS 2009; 3(2)

  Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus – Project Protocol. Optimal Therapy Report - COMPUS 2008; 3(1)